Mucosal Immunity
27.6K views | +7 today
Follow
 
Scooped by Gilbert C FAURE
onto Mucosal Immunity
March 8, 2020 4:59 AM
Scoop.it!

Bovine Coronavirus - an overview | ScienceDirect Topics

Bovine Coronavirus - an overview | ScienceDirect Topics | Mucosal Immunity | Scoop.it
Bovine Coronavirus Related terms: View all Topics Coronaviridae In Fenner's Veterinary Virology (Fifth Edition), 2017 CORONAVIRUSES of Cattle and Horses BOVINE CORONAVIRUS Bovine coronavirus infections are associated with three distinct clinical syndromes in cattle: calf diarrhea, winter dysentery (hemorrhagic diarrhea) in adult cattle, and respiratory infections in cattle of various ages, including the bovine respiratory disease complex (shipping fever) in feedlot cattle. Coronaviruses were first reported as a cause of diarrhea in calves in the United States in 1973, and since then they have been recognized worldwide in association with the three clinical syndromes. The economic impact of respiratory disease and calf diarrhea is considerable. Although many coronaviruses have restricted host ranges, betacoronaviruses such as bovine and SARS coronaviruses (Table 24.1) can infect other animal species, including wildlife. Bovine coronavirus is closely related to the human coronavirus OC43 that causes the common cold; indeed, OC43 has been proposed to represent prior zoonotic transmission of bovine coronavirus. Bovine coronavirus has also been shown to infect dogs subclinically and to infect turkey poults, leading to fecal virus shedding, diarrhea, seroconversion, and transmission to contact controls. Genetically and/or antigenically related bovine coronavirus variants have been isolated from dogs with respiratory disease, humans with diarrhea, and captive or wild ruminants with intestinal disease similar to winter dysentery of cattle. The latter include Sambar deer (Cerous unicolor), waterbuck (Kobus ellipsiprymnus), giraffe (Giraffa camelopardalis), and white-tailed deer (Odocoileus virgineanus). Bovine coronavirus has also been linked to enteric disease in South American camelids. Interestingly, the human enteric coronavirus and wild ruminant coronaviruses both infected and caused diarrhea in experimentally exposed gnotobiotic calves, and the inoculated calves were subsequently immune to infection with bovine coronavirus. Despite the different disease syndromes and apparent interspecies transmission of bovine coronavirus and its variants, only a single serotype of bovine coronavirus is recognized, and there is little sequence diversity between the wild ruminant coronaviruses and coronaviruses associated with the different disease syndromes in cattle. Furthermore, there are few common sequence differences to explain differences in host or tissue tropism. The host cell receptor for bovine coronavirus is sialic acid, which reflects the wide tropism of this virus and explains the presence of a HE gene in the virus. Clinical Features and Epidemiology Coronavirus-induced diarrhea commonly occurs in calves under 3 weeks of age after the decline of passively acquired antibodies, but disease can occur in calves up to 3 months of age. The severity of diarrhea and dehydration depends on the infecting dose as well as the age and immune status of the calf. Coinfections with other enteric pathogens such as rotavirus, torovirus, cryptosporidia, and enterotoxigenic or enteropathogenic E. coli are common; their additive or synergistic effects increase the severity of diarrhea. Calf coronavirus diarrhea is often seasonal, being more common in winter in part because of the increased stability of the virus in the cold. Bovine coronavirus has also been implicated as a cause of winter dysentery, a sporadic, acute enteric disease of adult cattle worldwide that is especially prevalent during winter months, as the name implies. Winter dysentery is characterized by explosive, often bloody diarrhea, accompanied by decreased milk production, depression, anorexia, and frequent respiratory signs. Morbidity rates range from 20% to 100% in affected herds, but mortality rates are usually low (1–2%). A similar winter dysentery syndrome associated with bovine coronaviruses variants occurs in captive and wild ruminants. This finding suggests that certain wild ruminants (deer, elk, caribou, etc.) that share common grazing areas with cattle could be a reservoir for coronavirus strains transmissible to cattle, or vice versa. Bovine coronavirus also causes mild respiratory disease (coughing, rhinitis) or pneumonia in 2–6-month-old calves. An epidemiologic study of calves from birth to 20 weeks of age confirmed both fecal and nasal shedding of coronavirus, with diarrhea prominent upon initial infection. The calves subsequently shed virus intermittently via the respiratory route, with or without signs of disease, suggesting that long-term mucosal immunity in the upper respiratory tract is ineffective in mediating virus clearance. As a consequence, coronavirus may recycle among cattle of all ages and regardless of their immune status, with sporadic nasal or fecal shedding from individual animals. Alternatively, new virus strains may be introduced when cattle from different sources are comingled, or from cohabiting wild ruminants. Since 1993, bovine coronavirus has been incriminated as a precipitating cause of the bovine respiratory disease (shipping fever) complex. Both respiratory and enteric shedding of bovine coronavirus are common in affected feedlot cattle, peaking shortly after arrival at feedlots. Since its discovery, bovine coronavirus repeatedly has been identified in the lungs of feedlot cattle that died with bovine respiratory disease complex. Most feedlot cattle also seroconvert to bovine coronavirus within 3 weeks of arrival. Importantly, studies suggest that cattle arriving at feedlots with high serum titers of bovine coronavirus antibody were less likely to shed virus or to develop shipping fever. This observation suggests a role for serum antibodies in protection, or as an indicator of recent infection and active immunity. Pathogenesis and Pathology Concurrent fecal and nasal virus shedding persists for up to 10 days after coronavirus infection of calves. Coronavirus antigen is commonly detected in epithelial cells of both the upper respiratory and intestinal tracts, and occasionally in the lung. The pathogenesis of coronavirus enteritis in calves is similar to that caused by rotavirus, with the notable exception of extensive involvement of the large intestine by coronavirus. Disease occurs most commonly in calves at about 1–3 weeks of age, when virus exposure increases and antibody titers in the dam’s milk begin to wane. The pathogenesis and consequences of enteric coronavirus infection of calves are similar to those described for transmissible gastroenteritis in piglets. The destruction of the mature absorptive cells lining the intestinal villi and mucosal surface in the large intestine leads to maldigestion and malabsorption, with rapid loss of water and electrolytes. The resultant hypoglycemia, acidosis, and hypovolemia can progress to circulatory failure and death, especially in very young animals. The pathogenesis and lesions of winter dysentery of dairy and beef cattle resemble those of calf diarrhea, but often with marked intestinal hemorrhage and extensive necrosis of cells within the crypts of the large intestinal mucosa. Nasal and fecal shedding is more transient (up to 4–5 days). The anorexia and depression seen in dairy cattle with winter dysentery may explain the precipitous and sometimes prolonged decrease in milk production. The cause of the acute and often voluminous bloody diarrhea in some cattle is unexplained. Both nasal and fecal shedding of bovine coronavirus can occur soon after cattle are transported to feedlots. Coronavirus infection is probably important in predisposing cattle entering feedlots to secondary bacterial infection that results in the characteristic shipping fever pneumonia—a severe, often fatal fibrinous bronchopneumonia caused by Mannheimia haemolytica biotype A, serotype 1 infection. Bovine coronavirus antigen also has been detected in epithelial cells of the upper (trachea, bronchi) and lower (terminal bronchioles and alveoli) respiratory tract of some affected cattle, but the precise role of coronavirus in precipitating the bovine respiratory disease complex awaits definitive characterization. Diagnosis Initially, the diagnosis of enteric bovine coronavirus infections was based on the detection of virus by electron microscopy. Cell culture isolation became a viable option when it was discovered that the virus could be grown when trypsin was added to the medium—virus replication is recognized by hemadsorption or cytopathogenic effects, and the presence of coronavirus is confirmed by diagnostic tests. An array of assays is now available for detection of bovine (or variant) coronaviruses in cell culture or diagnostic specimens such as feces or nasal swabs, including ELISAs that incorporate monoclonal antibodies for antigen capture, immune electron microscopy using hyperimmune antiserum, and RT-PCR using bovine coronavirus or pan-coronavirus-specific primers to detect viral RNA. The use of RT-PCR for detection of bovine coronavirus has significantly increased the detection of this agent, particularly in respiratory samples, and has also substantially increased the recognized period of virus shedding by infected animals. Postmortem diagnosis is performed on acute fresh or fixed respiratory or intestinal tissues using hyperimmune antisera or monoclonal antibodies for immunofluorescence or immunohistochemical tissue staining. Immunity, Prevention, and Control Passive Immunity to Enteric Bovine Coronavirus Infections in Calves Because coronavirus diarrhea occurs in young calves during the nursing period, maternal vaccination is required to provide immediate passive (lactogenic) immunity. Passive immunity to enteric viral infections in calves correlates with high levels of IgG1 antibodies in colostrum and milk. In ruminants, IgG1 antibodies are dominant in colostrum and milk and are selectively transported from serum. Most adult cattle are seropositive for antibodies to bovine coronavirus. Therefore, parenteral vaccination of mothers with adjuvanted inactivated bovine coronavirus vaccines effectively boosts IgG1 antibody titers in serum and mammary secretions, to provide enhanced passive immunity to calves. Immunity to Respiratory Bovine Coronavirus Infections The correlates of immunity to respiratory coronavirus infections in cattle are not clearly defined. The serum antibody titer to bovine coronavirus may be a marker for respiratory protection, as coronavirus-specific antibody titers and isotype (IgG1, IgG2, IgA) were correlated with protection of calves and feedlot cattle against subsequent occurrence of respiratory disease, pneumonia, or coronavirus shedding. However, it can be difficult to distinguish whether serum antibodies are correlates of protection, or whether they merely reflect prior enteric or respiratory coronavirus infection. Intranasal vaccination using live-attenuated enteric coronavirus vaccine has been proposed to reduce the risk of bovine respiratory disease complex (so-called “shipping fever”) in cattle entering feedlots. Respiratory System Jeff L. Caswell, Kurt J. Williams, in Jubb, Kennedy & Palmer's Pathology of Domestic Animals: Volume 2 (Sixth Edition), 2016 Bovine coronavirus. Bovine coronavirus (BCoV) is an important cause of enteric disease in young calves, and the same strains occasionally induce respiratory disease in calves 2-16 weeks of age. BCoV is a less frequent but nonetheless important cause of respiratory disease in calves, and deserves more attention than it has received in the past. Isolates from occurrences of respiratory and diarrheic diseases have similar genotypes, and a single outbreak may include both forms of disease. Respiratory signs include fever, serous nasal discharge, sneezing, and coughing. The virus replicates primarily in the nasal and tracheal epithelium, and occasionally in the lung. Many calves shed BCoV in their nasal secretions and/or seroconvert to BCoV in the first month after arrival in feedlots, but the association between seroconversion or virus shedding and increased risk of respiratory disease has been variable in the studies reported. Bronchiolar necrosis is the typical lesion seen in BCoV-infected calves (eFig. 5-83). Bronchiolar syncytia have been described in feedlot calves with concurrent BCoV infection and bacterial pneumonia, but the contribution of other viruses, such as bovine respiratory syncytial virus, to these lesions is uncertain. BCoV may be demonstrated using immunohistochemistry or RT-PCR, or isolated using specific rectal tumor cell lines. Further reading Bidokhti MR, et al. Tracing the transmission of bovine coronavirus infections in cattle herds based on S gene diversity. Vet J 2012;193:386-390. Fulton RW, et al. Bovine coronavirus (BCV) infections in transported commingled beef cattle and sole-source ranch calves. Can J Vet Res 2011;75:191-199. Park SJ, et al. Dual enteric and respiratory tropisms of winter dysentery bovine coronavirus in calves. Arch Virol 2007;152:1885-1900. Storz J, et al. Isolation of respiratory bovine coronavirus, other cytocidal viruses, and Pasteurella spp from cattle involved in two natural outbreaks of shipping fever. J Am Vet Med Assoc 2000;216:1599-1604. Storz J, et al. Coronavirus and Pasteurella infections in bovine shipping fever pneumonia and Evans' criteria for causation. J Clin Microbiol 2000;38:3291-3298. Diseases of the Respiratory System In Veterinary Medicine (Eleventh Edition), 2017 Bovine Coronavirus Bovine coronavirus (BoCV) is one of the more newly identified viral respiratory pathogens of cattle, being first described in 1993. As a consequence, the clinical significance of BoCV in bovine respiratory disease, and enzootic pneumonia in particular, is still being determined. The current evidence indicates that BoCV plays a primary and important role in enzootic pneumonia. BoCV was the most commonly identified viral pathogen identified in nasal swabs from calves with respiratory disease in Ireland, being present in 23% of calves.3 BoCV was identified throughout the year, but at a much lower rate in summer.3 BoCV was the only virus detected in approximately 75% of respiratory disease outbreaks in two to 3-month calves in Italy.4 Biology and Diseases of Ruminants (Sheep, Goats, and Cattle) Wendy J. Underwood DVM, MS, DACVIM, ... Adam Schoell DVM, DACLAM, in Laboratory Animal Medicine (Third Edition), 2015 Coronavirus Bovine coronavirus, of the family Coronaviridae, produces a more severe, long-lasting disease compared to rotavirus. Clinical signs in lambs and calves are similar to above, although the incubation period tends to be shorter (20–36 h). In addition, mild respiratory disease may be noted (Janke, 1989). Coronavirus infections may be complicated by parasite infestation (e.g., Cryptosporidia, Eimeria) or bacterial infections (e.g., E. coli, Salmonella). Treatment is aimed at correcting dehydration, electrolyte imbalances, and acidosis. Strict hygiene and effective passive transfer by developing good colostrum-management protocols are critical. Bovine vaccines are available both for delivery to pre-partum dams and for the neonate. Rotaviruses, coronavirus, and adenoviruses affect neonatal goats; however, little has been documented on the pathology and significance of these agents in this age group. Unlike calves, it appears that bacteria play a more important role in neonatal kid diarrheal diseases than in neonatal calf diarrheas. Parvovirus and BVDV also may cause diarrhea in neonatal calves. Viral Diseases of the Bovine Respiratory Tract Robert W. Fulton, in Food Animal Practice (Fifth Edition), 2009 BOVINE CORONAVIRUS Bovine coronaviruses (BCVs) were initially associated with neonatal calf diarrhea.15 Then BCVs were identified with “winter dysentery” in adult dairy cattle.7,15 Later BCVs were detected in respiratory secretions of infected calves with subsequent isolation from cattle with BRD signs. This isolation of BCVs from calves with “shipping fever” pneumonias led to the assumption that BCVs were a major etiology for BRD. In some studies other agents such as BRSV, BVDV, and PI-3V along with bacteria were also found in these severely ill cattle. No doubt BCVs are found in conjunction with other respiratory tract infections, yet their sole or primary BRD role has not been clearly established. Including BCV along with other bovine respiratory tract viruses contributing to BRD is best. Clearly, experimental reproduction of detectable and severe respiratory tract disease such as pneumonia would better make the case for BCV as a significant primary pathogen in respiratory tract disease in cattle. Etiology/Epidemiology BCVs are RNA viruses of the viral family Coronaviridae.6,15 They are enveloped viruses, thus sensitive to disinfectants and the environment. It is not unexpected that cattle would have a coronavirus with tropism for the respiratory tract. Coronaviruses infect the respiratory tract of other species including humans, pigs, turkeys, and chickens. BCV infections in cattle are worldwide. Initially implicated in neonatal calf diarrhea, BCVs were also reported with etiology in “winter dysentery” of adult cattle. Subsequently BCVs have been isolated from the nasal samples of cattle undergoing respiratory tract disease.62-66 Thus this virus has a purported role in both respiratory tract disease and enteric diseases. Only one serotype is recognized, but likely there is some antigenic variability.15 The dilemma for working with BCV experimentally and diagnostic laboratories attempting to isolate the virus is that BCV replicates poorly or is quite difficult to isolate in standard cell cultures. A specialized cell line, a human rectal adenocarcinoma line, is permissive for BCV and has been used for virus isolation from feces and nasal swabs by selected laboratories. The BCV is considered relatively common in enteric infections in both beef and dairy operations. The virus has been isolated from cells with disease including calf pneumonias, as well as beef cattle entering feedlots in various U.S. regions. The BCV was isolated from both healthy and sick cattle in these BRD episodes. And BCV was detected by seroconversions during the first month in feedlots in transported cattle. Clinical Disease The association of BCV with BRD has been primarily by the isolation of virus from nasal swabs of cattle with BRD signs and seroconversions to BCV. The virus has been found in healthy calves as well. Likewise, antibody testing has detected seroconversions in cattle in BRD cases. The clinical signs in the BRD cases are not unlike other BRD cases with viral etiologies present such as BVDV; PI-3V; BRSV; and other viruses with fever, nasal and ocular discharges, anorexia, and coughing. Typically these BCV isolations and seroconversions occur soon after arrival to the feedlot. As expected there is often involvement of secondary bacteria such as M. haemolytica and/or P. multocida. Attempts have been made to demonstrate the pathogenicity of BCV for the bovine respiratory tract. After experimental challenge in young calves, the virus could be found in feces of diarrheic calves and nasal swabs for up to 5 days.15 Respiratory disease signs occurred in only a few calves. Lesions of emphysema and interstitial pneumonia were evident in only a few calves.67,68 For other studies, there are mixed reports of BCV detected in lung tissues of cattle with BRD, one report with no BCV detection in lungs of cattle with BRD,6 and another detecting BCV antigen by immunofluorescence in respiratory tissues.69 Diagnosis The virus can be isolated in cell culture provided that a unique cell culture is available to the diagnostic laboratory, the human rectal adenocarcinoma line (HRT-18).15 The nasal swabs collected appear to be the choice of collections from live cattle for testing. An antigen capture ELISA originally used for detecting BCV antigen in fecal samples is also used by some diagnostic laboratories for BCV detection in respiratory disease samples. Also, BCV immunofluorescence is available to detect BCV antigen. Selected diagnostic laboratories and research units have used PCR to detect BCV in diagnostic samples. Use of electron microscopy could detect BCV in respiratory samples similar to the use of EM for fecal samples. Selected research laboratories have used ELISA tests for BCV antibodies, and in some selected studies they found seroconversions when paired samples were available. Clinicians should consult with their respective diagnostic laboratory for their testing for BCV. Prevention and Control Although there are licensed BCV vaccines for enteric disease protection, there are no licensed BCV vaccines in the United States to control respiratory tract disease in cattle. Treatment focuses on the use of antimicrobials to control the bacterial secondary infections. As in prevention of the neonatal enteric disease, it is assumed that adequate colostrum is available to provide protection in the young calf. Diseases of the Alimentary Tract–Ruminant In Veterinary Medicine (Eleventh Edition), 2017 Synopsis Etiology Bovine coronavirus. Epidemiology Northern climates. Adult lactating dairy cows, usually during winter months when housed. Immunity develops and lasts variable periods. High morbidity with outbreaks; low mortality. Transmitted by fecal–oral route. Signs Sudden onset of diarrhea affecting almost entire herd within several days. Mild fever, decline in milk production, inappetence. Recover in few days. Some coughing. Clinical pathology None routinely. Lesions Crypt atrophy on intestinal mucosa; enterocolitis. Diagnostic confirmation Detection of virus in feces. Serology. Treatment None required. Control No specific control measures available. Hygiene. Minimize overcrowding in dairy housing. Alimentary System Francisco A. Uzal, ... Jesse M. Hostetter, in Jubb, Kennedy & Palmer's Pathology of Domestic Animals: Volume 2 (Sixth Edition), 2016 Bovine coronavirus. In neonatal calves, Bovine coronavirus (BCoV) infection is a common cause of diarrhea, either alone or in combination with other agents, particularly Rotavirus and Cryptosporidium. The disease may be severe in combination with BVDV infection. BCoV is capable of infecting absorptive epithelium in the full length of the small intestine, and in the large bowel. Viral antigen is also found in macrophages in the lamina propria of villi and in mesenteric lymph nodes. In field infections, microscopic lesions are found most consistently in the lower small intestine and colon. Calves with BCoV infection usually develop mild depression, but continue to drink milk despite developing profuse diarrhea. With progressive dehydration, acidosis, and hyperkalemia, the animals become weak and lethargic; death can ensue as a result of hypovolemia, hypoglycemia, and potassium cardiotoxicosis. Diarrhea in survivors resolves in 5-6 days. At autopsy, affected animals have the nonspecific lesions of undifferentiated neonatal calf diarrhea. Rarely, mild fibrinonecrotic typhlocolitis is recognized in calves with coronaviral infection. Mesenteric lymph nodes may be somewhat enlarged and wet. Virus replication is cytocidal and initially occurs throughout the length of the villi in all levels of the small intestine, eventually spreading throughout the large intestine up to the end of the large colon and rectum, causing a malabsorptive diarrhea. Large concentration of BCoV can be typically found in the spiral colon. Infected epithelial cells die, slough off, and are replaced by immature cells. The microscopic lesions of coronaviral infection in calves vary with the severity and duration of the infection; villus atrophy in combination with mild colitis is typical (Fig. 1-114). In the calf small intestine, villus atrophy is rarely as severe as that seen in neonatal swine with TGE. Rather, villi are moderately shortened, or have subtotal atrophy with stumpy, club-shaped, or pointed tips, and villus fusion may be common. In the early phase of the clinical disease, villi are often pointed and covered by cuboidal to squamous epithelium. Exfoliation of epithelium and microerosion may be evident. Later, the epithelium is cuboidal to low columnar, basophilic, with irregular nuclear polarity and an indistinct brush border. Cryptal epithelium is hyperplastic. The lamina propria may contain a moderate infiltrate of mainly mononuclear inflammatory cells, some of which may have pyknotic or karyorrhectic nuclei. In the early stages of infection, necrosis of cells in mesenteric lymph nodes is associated with viral replication. Peyer's patches in animals examined after 4-5 days of clinical illness often appear involuted, and are dominated by histiocytic cells. Whether this is the result of viral activity or the effect of endogenous glucocorticoids is unclear. In the colon during the early phase of infection, surface epithelium may be exfoliating, flattened, and squamous or eroded in patchy areas. Some colonic glands may be dilated, lined by flattened epithelium and contain exfoliated cells and necrotic debris. A moderate mixed inflammatory reaction is present in the lamina propria, and neutrophils may be in damaged glands or effusing into the lumen through superficial microerosions. Later in infection, some dilated debris-filled colonic glands will remain, but other glands will be lined by hyperplastic epithelium, and the surface epithelium will be restored to a cuboidal or low columnar cell type. Goblet cells are usually relatively uncommon. Colonic lesions may be recognizable in tissues from animals submitted dead, even though postmortem change has obscured changes in the small intestine. Live calves in the early stages of clinical disease are the best subjects for confirmation of an etiologic diagnosis. In calves becoming ill <7 days of age, enterotoxigenic Escherichia coli is the main alternative diagnosis. Rotavirus, Cryptosporidium, and combined infections must be considered in calves 5-15 days of age. Infectious bovine rhinotracheitis, salmonellosis, and bovine viral diarrhea must also be considered. Both salmonellosis and bovine viral diarrhea may be associated with depletion of Peyer's patches and colitis that can be confused with that of coronaviral infection; neither is common in the strictly neonatal age group (<7-14 days of age). Respiratory tract infection also occurs in calves and feeders infected with BCoV. The virus replicates in the epithelium of the nasal turbinates and tracheobronchial tree, and respiratory infection may precede, be concurrent with, or follow enteric infection. Calf pneumonia caused by BRCoV can be observed in calves 6-9 months of age. Affected animals may develop fever, serous to mucopurulent nasal discharge, coughing, tachypnea, and dyspnea. Respiratory infections may play a role in maintaining the virus within a herd, and significant, but poorly characterized, pneumonia has been reported in some experimentally infected calves. In addition, coronaviral infection may predispose to subsequent respiratory bacterial infections or contribute to more severe respiratory disease as part of the shipping fever syndrome. Virus may be identified in tissue or nasal secretions by immunofluorescence or immunohistochemistry. Winter dysentery is a syndrome in adult cattle that has been associated with BCoV in a number of areas around the world. Animals develop blood-tinged diarrhea, nasolacrimal discharge or cough, anorexia, and drop in milk production. Mortality is rare, but may occur. The disease is characterized by a high morbidity rate ranging from 50-100%, but usually low mortality rate, typically <2%. Winter dysentery outbreaks are predominantly seen in young postpartum dairy cows, which then experience a drop of 25-95% in milk production. Occasional cases are also observed in adult dairy and beef cattle. Despite its name, cases of winter dysentery can be observed, albeit infrequently, during the warmer season. The pathophysiologic characteristics of winter dysentery are mostly attributed to lesions of the colonic mucosa. Grossly, the colon of affected animals has linear congestion and hemorrhage along the crests of mucosal folds and there may be a large amount of blood mixed with colonic contents (Fig. 1-115). The histologic lesions are similar to those seen in calves with classical BCoV diarrhea, although they are mostly restricted to the colon with only occasional lesions seen in the terminal small intestine. Large amount of BCoV can be detected in colonic epithelium by immunohistochemistry. Coronaviruses are commonly demonstrated in the feces of cattle with winter dysentery; seroconversions occur, and seroprevalence increases in affected herds. Coronavirus antigen is found in the colonic glands of affected animals, in which there is necrosis and exfoliation of epithelial cells. Certain management practices, notably housing animals in stanchions and use of equipment that handles both manure and feed, have been associated with the development of winter dysentery. Further reading Blanchard PC. Diagnostics of dairy and beef cattle diarrhea. Vet Clin North Am Food Anim Pract 2012;28:443-464. Boileau MJ, et al. Bovine coronavirus associated syndromes. Vet Clin North Am Food Anim Pract 2010;26:123-146. Cho KO, et al. Detection and isolation of coronavirus from feces of three herds of feedlot cattle during outbreaks of winter dysentery-like disease. J Am Vet Med Assoc 2000;217:1191-1194. Heckert RA, et al. Epidemiologic factors and isotype-specific antibody responses in serum and mucosal secretions of dairy calves with bovine coronavirus respiratory tract and enteric tract infections. Am J Vet Res 1991;52:845-851. Kanno T. Bovine coronavirus infection: pathology and interspecies transmission. J Disast Res 2012;7:293-302. Kapil S, et al. Experimental infection with a virulent pneumoenteric isolate of bovine coronavirus. J Vet Diagn Invest 1991;3:88-89. Natsuaki S, et al. Fatal winter dysentery with severe anemia in an adult cow. J Vet Med Sci 2007;69:957-960. Park SJ, et al. Dual enteric and respiratory tropisms of winter dysentery bovine coronavirus in calves. Arch Virol 2007;152:1885-1900. Saif LJ, et al. Winter dysentery in dairy herds: electron microscopic and serological evidence for an association with coronavirus infection. Vet Rec 1991;128:447-449. Smith DR, et al. Epidemiologic herd-level assessment of causative agents and risk factors for winter dysentery in dairy cattle. Am J Vet Res 1998;59:994-1001. Traven M, et al. Experimental reproduction of winter dysentery in lactating cows using BCV—comparison with BCV infection in milk-fed calves. Vet Microbiol 2001;81:127-151. Zhang Z, et al. Application of immunohistochemistry and in situ hybridization for detection of bovine coronavirus in paraffin-embedded, formalin-fixed tissues. J Clin Microbiol 1997;35:2964-2965. Infectious Diseases of the Gastrointestinal Tract Simon F. Peek, ... Kevin J. Cummings, in Rebhun's Diseases of Dairy Cattle (Third Edition), 2018 Etiology Based on seroprevalence studies, the bovine coronavirus (BCoV) responsible for calf diarrhea is quite prevalent in U.S. cattle herds, as is rotavirus. There is much debate among researchers at this point as to whether BCoV isolates obtained from calf and adult diarrhea cases are the same virus or distinct from those that have been incriminated in respiratory disease outbreaks in feedlot and dairy calves. Whether or not there are antigenic or genomic differences in BCoV strains that mediate different organ tropism is similarly unclear. Winter dysentery in adult cattle has been associated with BCoV, and the same strain that causes diarrhea in calves has been used to experimentally create winter dysentery in adult cattle. Therefore, the upper age limit of susceptibility to infection by this agent is apparently longer than traditionally thought. Although not as common as rotavirus as a cause of viral enteritis in dairy calves, coronavirus has been identified in neonatal calf diarrhea outbreaks, especially in the winter months and with mixed infections. A number of studies indicate that clinical disease associated with BCoV in calves is more severe than rotavirus, with higher mortality rates. Affected calves tend to be slightly older than calves infected with pure ETEC or pure rotavirus. They average 7 to 10 days of age at onset, with some observed as late as 3 weeks of age. The virus causes a severe enterocolitis characterized by villous enterocyte destruction in the small intestine and destruction of both ridges and crypts in the large intestine. Maldigestion, malabsorption, and inflammation all contribute to the pathophysiology of coronavirus diarrhea in calves. The virus is cytolytic, and affected villous enterocytes in the small intestine are replaced by cuboidal cells from the crypts, but the colonic lesions leave denuded mucosa in affected areas of the colon. The severity of this damage helps explain why coronavirus enteritis, unlike rotavirus, may cause some flecks of blood to appear in the stool and can kill calves even in a germ-free isolation facility. Thus, in the natural setting, coronavirus enteritis creates a severe clinical diarrhea and can also be associated with > 50% mortality when combined with other viral, bacterial and C. parvum infections.
No comment yet.
Mucosal Immunity
The largest immune tissue in the body
Your new post is loading...
Your new post is loading...
Scooped by Gilbert C FAURE
December 27, 2013 10:35 AM
Scoop.it!

Mucosal Immunity

is the most recent part of Immunology!

It appeared less than 40 years ago, while systemic immunity exploded 60  years ago.

It is still a minor part of Immunology teaching and research, while the mucosal immune system is at the frontline of encounters with germs, antigens... in other words the environment.

 

major keywords:

> 450 posts IgA http://www.scoop.it/t/mucosal-immunity?q=IgA

> 125 posts tolerance http://www.scoop.it/t/mucosal-immunity?q=tolerance

> 400 posts : microbiome http://www.scoop.it/t/mucosal-immunity?q=microbiome

 

july 2015: almost 2100 scoops, >1700 visitors, >3900 views

november 2017 >10K views of >3300 scoops

june 2020 >17.6K views, >5.5K visitors,  >4.5K scoops

may 2024 >22K views, >6.9 visitors,  >5.2 scoops

Gilbert C FAURE's insight:

This topic complements the more general Immunology topic.

 http://www.scoop.it/t/immunology

 

It includes also reproductive immunology (#100posts) searchable on

http://www.scoop.it/t/mucosal-immunity?q=reproductive

https://www.scoop.it/t/mucosal-immunity/?&tag=REPRODUCTION

 

and  also covers lung immunology (>350 posts)

http://www.scoop.it/t/mucosal-immunity?q=lung

 

Covid (>200 posts) can be found on 

https://www.scoop.it/topic/mucosal-immunity?q=covid

 

Vaccines (>250 posts) are available on

https://www.scoop.it/topic/mucosal-immunity?q=vaccines

 

No comment yet.
Scooped by Gilbert C FAURE
March 27, 5:10 AM
Scoop.it!

Lancet | Madhukar Pai, MD, PhD

Lancet | Madhukar Pai, MD, PhD | Mucosal Immunity | Scoop.it
World TB Day is a great time to pick up John Green's new book "Everything is Tuberculosis"!

My review of his book in The Lancet Group 👇

https://lnkd.in/gq2eMvPA
No comment yet.
Scooped by Gilbert C FAURE
March 22, 6:31 AM
Scoop.it!

#immunology #immunity #systemsimmunology #vaccines #spatialtranscriptomics #singlecell #multiomics | Matthieu Pesant

#immunology #immunity #systemsimmunology #vaccines #spatialtranscriptomics #singlecell #multiomics | Matthieu Pesant | Mucosal Immunity | Scoop.it
🧬 Programming lung immunity through mucosal vaccination

A new Science Magazine study shows how intranasal vaccination can induce broad protection against diverse respiratory threats in mice.

Using an intranasal liposomal formulation combining TLR4 and TLR7/8 agonists with antigen, the authors demonstrate durable protection against multiple viral and bacterial respiratory infections, as well as allergic airway inflammation.

Multi-omic profiling of lung tissue reveals several key features of this response:

🔹 Durable tissue-resident T cell immunity
Intranasal vaccination induces persistent antigen-specific CD4⁺ and CD8⁺ tissue-resident memory T cells (TRM) in the lung that remain detectable for months.

🔹 Epigenetic reprogramming of alveolar macrophages
Single-cell transcriptomic and chromatin accessibility analyses reveal sustained transcriptional and epigenomic remodeling of alveolar macrophages, enhancing antigen presentation, phagocytosis, and antiviral responses.

🔹 T cell–innate cell cross-talk via RANKL signaling
Memory T cells imprint macrophage function through RANKL-mediated signaling, establishing a feed-forward circuit between adaptive and innate immunity within lung tissue.

🔹 Rapid spatial immune organization upon infection
Following challenge, vaccinated lungs rapidly form tertiary lymphoid structures, enabling accelerated pathogen-specific T- and B-cell responses.

These findings support the concept of “integrated organ immunity” - a coordinated network of tissue-resident immune and structural cells that can provide broad protection against diverse respiratory threats.

💡 The study also highlights how integrating spatial transcriptomics, single-cell RNA-seq, and chromatin accessibility profiling enables detailed mapping of immune programming directly within lung tissue microenvironments.

📄 Zhang et al., Science (2026)
Mucosal vaccination in mice provides protection from diverse respiratory threats

👉 Read the full study here:
https://lnkd.in/d4uzxQCD

📊 Graphical abstract adapted from the article.

#Immunology #Immunity #SystemsImmunology #Vaccines #SpatialTranscriptomics #SingleCell #Multiomics
No comment yet.
Scooped by Gilbert C FAURE
March 13, 8:25 AM
Scoop.it!

Mucosal glycans: key drivers of the development of inflammatory bowel disease and a potential new therapeutic target | Nature Reviews Gastroenterology & Hepatology

Mucosal glycans: key drivers of the development of inflammatory bowel disease and a potential new therapeutic target | Nature Reviews Gastroenterology & Hepatology | Mucosal Immunity | Scoop.it
Glycans are essential components of homeostatic networks, acting as fine tuners of immunological responses, and are therefore promising targets for manipulating immune tolerance. Glycans shield the entire gut mucosa surface, contributing to epithelial barrier integrity. Moreover, most microorganisms expose glycoconjugates on their surfaces, making glycans essential molecules in the crosstalk between host immune response and the gut microbiota. The vast amount of biological information encoded by mucosal glycans is deciphered by a variety of glycan-binding proteins that translate glycan recognition into either pro-inflammatory or anti-inflammatory responses. Current evidence from inflammatory bowel disease (IBD) has highlighted the prominent role of glycans in establishing and regulating key cellular and molecular pathways underlying the transition from health to intestinal inflammation, with implications for understanding IBD immunopathogenesis and for IBD prediction and prevention. In this Review, we discuss current advances, emerging challenges and future prospects in exploiting the power of the mucosal glycocalyx and the glycome as master coordinators of the immunoregulatory networks in IBD from the preclinical phase to established diagnosis. We discuss the clinical utility of the glycome as a serological biomarker with diagnostic, prognostic and predictive value, and as a potential new target for preventive intervention strategies in IBD. Glycans are essential components of the gut mucosa that modulate epithelial barrier integrity, host–microbiota interactions and gut immune response. This Review discusses the role of mucosal glycans in gut homeostasis, in intestinal inflammation and their therapeutic potential for inflammatory bowel disease.
No comment yet.
Scooped by Gilbert C FAURE
March 2, 4:11 AM
Scoop.it!

#microbiote #biologiemédicale #biomarqueurs #sfm #ebm #métagénomique #micmac | Société Française de Microbiologie

#microbiote #biologiemédicale #biomarqueurs #sfm #ebm #métagénomique #micmac | Société Française de Microbiologie | Mucosal Immunity | Scoop.it
Un grand merci à Biologiste365 d’avoir permis un débat ouvert et utile autour de “Microbiote intestinal : de la recherche à la clinique”.
Les échanges (et le replay) sont ici : https://lnkd.in/ev3hj_HC
Pour la Société Française de Microbiologie et son GT MicMaC, le message reste constant, déjà porté dans notre tribune (Le Monde, 2023 – https://lnkd.in/ekh2EgXC) : oui à la recherche encadrée sur le microbiote, mais non aux raccourcis, potentiellement dangereux pour les patients.
L’étude portée par MicMaC (Pichon et al., Gut 2025 – https://lnkd.in/eYCweCfW) l’a objectivé : à partir d’un même échantillon de selles standardisé, des offres d’analyse du microbiote “en libre accès” auprès des particuliers produisent à l’heure actuelle des résultats et des interprétations très variables, donc non fiables, et d’aucune utilité. Quand le rendu dépend du laboratoire, ce n’est pas un biomarqueur clinique, et cela ne doit pas guider des décisions de santé.
Ce que nous défendons est simple et pragmatique :
·      standardiser (pré-analytique, analytique, bioinformatique)
·      valider (recherche clinique, cohortes, réplication, impact clinique)
·      encadrer l’interprétation (s’appuyer sur des connaissances médicales et le dialogue clinico-biologique, pas de sur-promesses)
La SFM continuera à pousser une approche exigeante, transparente et centrée sur le patient, pour faire du microbiote un vrai progrès clinique.

Geneviève HÉRY-ARNAUD
#Microbiote #BiologieMédicale #Biomarqueurs #SFM #EBM #Métagénomique #MicMaC
No comment yet.
Scooped by Gilbert C FAURE
February 21, 4:02 AM
Scoop.it!

Mucosal vaccination in mice provides protection from diverse respiratory threats

No comment yet.
Scooped by Gilbert C FAURE
February 17, 12:55 PM
Scoop.it!

#vaccines #influenza #covid19 #rsv #hmpv #hpiv #health #globalhealth #publichealth #medicine #biotechnology #medicine #pharmaceuticals #fda #cdc #who #ecdc | Juan Lama

#vaccines #influenza #covid19 #rsv #hmpv #hpiv #health #globalhealth #publichealth #medicine #biotechnology #medicine #pharmaceuticals #fda #cdc #who #ecdc | Juan Lama | Mucosal Immunity | Scoop.it
Harnessing Mucosal Immunity for Protective Vaccines -

A thorough review on mucosal immunity, the type of responses elicited, the unique anatomical and immunological features of the mucosal surfaces of the body, and the challenges associated with the generation of protective immunity via mucosal vaccines.

https://sco.lt/8hqDuy

#vaccines #influenza #Covid19 #RSV #HMPV #HPIV #health #globalhealth #publichealth #medicine #biotechnology #medicine #pharmaceuticals #FDA #CDC #WHO #ECDC
No comment yet.
Scooped by Gilbert C FAURE
February 15, 1:39 PM
Scoop.it!

WastewaterSCAN Dashboard | Emily Mosites

WastewaterSCAN Dashboard | Emily Mosites | Mucosal Immunity | Scoop.it
What does it mean if we find measles virus in a SEWER? I’m a few weeks into my new role as Vermont’s State Epidemiologist for Infectious Diseases and last week we detected measles virus in wastewater in the state, even though our team hadn’t found any cases of measles since last spring.

Measles virus isn’t usually in wastewater, so finding it there means that someone had measles in the area. They might have been a resident or someone traveling through (and who wouldn’t want to travel through Vermont??).

Fortunately, our epidemiology team has many “streams” of data (get it?). So, a few days later, we were able to identify a case of measles in a person living in the same area. Our epidemiologists connected with the patient to help prevent further spread.

We now know that wastewater is working for us as an early detection system. With rising measles throughout the United States, we will be keeping a close eye on it.

https://lnkd.in/gRQguCwB
No comment yet.
Scooped by Gilbert C FAURE
February 4, 6:43 AM
Scoop.it!

Genomics Reveals How Saharan Dust Impacts Portuguese Agriculture | MGI

Genomics Reveals How Saharan Dust Impacts Portuguese Agriculture | MGI | Mucosal Immunity | Scoop.it
Each year, vast clouds of dust journey from the Sahara to Europe. But they don't travel alone. They carry a hidden cargo of millions of microbes.

Now, a team from the University of Lisbon, powered by MGI's sequencing tools, is investigating how this invisible migration is reshaping Portuguese agriculture. Their discovery during Storm Célia—a bacterial genus with potential as a powerful bio-fertilizer—turns an environmental phenomenon into a beacon of biotechnological hope.
No comment yet.
Scooped by Gilbert C FAURE
February 1, 12:53 PM
Scoop.it!

Intranasal Bird Flu Vaccine Protects Against Highly Pathogenic Strains in Rodents

Intranasal Bird Flu Vaccine Protects Against Highly Pathogenic Strains in Rodents | Mucosal Immunity | Scoop.it
Prior seasonal influenza virus immunity did not impair antibody responses or protection conferred by the intranasal H5N1 vaccine.
Scooped by Gilbert C FAURE
January 14, 7:48 AM
Scoop.it!

GUT MICROBIOTA IN EARLY CHILDHOOD DEPENDS ON THE MICROBIOTA OF BREAST'S MILK The establishment of the gut microbiome in early life is critical for healthy infant development. Mother's milk is… |...

GUT MICROBIOTA IN EARLY CHILDHOOD DEPENDS ON THE MICROBIOTA OF BREAST'S MILK The establishment of the gut microbiome in early life is critical for healthy infant development. Mother's milk is… |... | Mucosal Immunity | Scoop.it
GUT MICROBIOTA IN EARLY CHILDHOOD DEPENDS ON THE MICROBIOTA OF BREAST'S MILK

The establishment of the gut microbiome in early life is critical for healthy infant development.

Mother's milk is crucial for shaping the infant gut microbiome by delivering beneficial bacteria, prebiotics, antibodies, and immune cells, fostering the growth of helpful microbes like Bifidobacterium and reducing pathogens, which is vital for immune development, nutrient absorption, and protection against chronic diseases.

This maternal transfer, via a gut-milk-infant pathway, helps establish a stable, healthy gut ecosystem that supports long-term health.

In an Open Access paper in Nature Communications, the results of an important study on the relationship between intestinal microbiota and breast milk in early childhood.

In this study, the authors quantified the similarity between the maternal milk and the infant gut microbiomes.

They used 507 metagenomic samples collected from 195 mother-infant pairs at one, three, and six months postpartum.

Microbial taxonomic overlap between milk and the infant gut was driven by Bifidobacterium longum, and infant microbiomes dominated by B. longum showed greater temporal stability than those dominated by other species.

They also identified numerous instances of strain sharing between milk and the infant gut, involving both commensal (e.g. B. longum) and pathobiont species (e.g. K. pneumoniae).

Shared strains also included typically oral species such as S. salivarius and V. parvula, suggesting possible transmission from the infant’s oral cavity to the mother’s milk.

At one month, the infant gut microbiome was enriched in biosynthetic pathways, suggesting that early colonisers might be more metabolically independent than those present at six months.

Lastly, they observed significant overlap in antimicrobial resistance gene carriage within mother-infant pairs.

Together, these results suggest that the human milk microbiome has an important role in the assembly, composition, and stability of the infant gut microbiome.

Ferretti, P., Allert, M., Johnson, K.E. et al. Nat Commun 16, 11536 (2025). https://lnkd.in/eD92fRkM
Scooped by Gilbert C FAURE
January 12, 8:57 AM
Scoop.it!

Deux études parues dans « Nature Cancer » décrivent comment des niveaux élevés de bactéries infiltrant les tumeurs affaiblissent la réponse immunitaire, favorisant une résistance à l’immunothérapie...

Deux études parues dans « Nature Cancer » décrivent comment des niveaux élevés de bactéries infiltrant les tumeurs affaiblissent la réponse immunitaire, favorisant une résistance à l’immunothérapie... | Mucosal Immunity | Scoop.it
Deux études parues dans « Nature Cancer » décrivent comment des niveaux élevés de bactéries infiltrant les tumeurs affaiblissent la réponse immunitaire, favorisant une résistance à l’immunothérapie dans les cancers de la tête et du cou.
No comment yet.
Scooped by Gilbert C FAURE
January 7, 4:45 AM
Scoop.it!

#bacteria #toxins #inflammation #alcohol #neutrophils #dna #microbes #gastroenterology #hepatology | Melvin Sanicas

#bacteria #toxins #inflammation #alcohol #neutrophils #dna #microbes #gastroenterology #hepatology | Melvin Sanicas | Mucosal Immunity | Scoop.it
Research shows that even a single episode of binge drinking - about four drinks for women or five for men within two hours - can weaken the gut barrier, allowing #bacteria and #toxins to enter the bloodstream and trigger #inflammation, a process often referred to as “leaky gut.”

▫️ Investigators at Beth Israel Deaconess Medical Center (BIDMC), in work published in Alcohol: Clinical and Experimental Research, found that short bursts of high-dose #alcohol recruit immune cells called #neutrophils to the upper small intestine, where they release damaging structures known as NETs that disrupt the gut lining.

▫️ NETs stands for Neutrophil Extracellular Traps. They are web-like structures made of #DNA, histones, and antimicrobial proteins that are released by neutrophils to trap and kill #microbes. While NETs are part of the body’s innate immune defense, they can also damage surrounding tissues when produced excessively or inappropriately - such as after binge alcohol exposure - by disrupting barriers like the gut lining, promoting inflammation, and allowing bacteria or toxins to leak into the bloodstream.

▫️ The study, led by Scott Minchenberg, MD, PhD, a clinical fellow in #gastroenterology and #hepatology at BIDMC, showed that breaking down these NETs with an enzyme reduced gut damage and bacterial leakage.

▫️ As noted by senior author Gyongyi Szabo MD, PhD, Chief Academic Officer at BIDMC and Beth Israel Lahey Health, these findings highlight an early inflammatory pathway linking binge drinking to gut and liver injury.

🗃️ See comments section for reference.
No comment yet.
Scooped by Gilbert C FAURE
March 27, 5:16 AM
Scoop.it!

Asthme : prévention, vaccination… et entretien pharmaceutique On parle souvent des risques infectieux chez les patients asthmatiques — grippe, pneumocoque — et de l’importance de la vaccination po...

Asthme : prévention, vaccination… et entretien pharmaceutique On parle souvent des risques infectieux chez les patients asthmatiques — grippe, pneumocoque — et de l’importance de la vaccination po... | Mucosal Immunity | Scoop.it
Asthme : prévention, vaccination… et entretien pharmaceutique

On parle souvent des risques infectieux chez les patients asthmatiques — grippe, pneumocoque — et de l’importance de la vaccination pour éviter des exacerbations sévères.

Mais un levier reste encore sous-exploité : l’entretien asthme.
👉 Un moment clé pour évaluer le contrôle de la maladie
👉 Un espace pour vérifier l’observance et la bonne utilisation des dispositifs
👉 Une opportunité pour sensibiliser à la prévention, notamment vaccinale
👉 Un point de contact régulier dans le parcours de soins

C’est un dispositif puissant… à condition qu’il soit réellement activé.
Aujourd’hui, le défi n’est plus seulement d’informer, mais de structurer et de systématiser ces interactions.

C’est là que la technologie peut faire la différence.

Chez Apodis, nous travaillons à :
✔️ Identifier les patients éligibles à l’entretien asthme
✔️ Aider les pharmaciens à structurer leurs interventions
✔️ Intégrer la prévention vaccinale dans chaque échange
✔️ Suivre l’impact dans le temps

L’entretien asthme ne doit plus être une opportunité ponctuelle, mais un véritable outil de pilotage du parcours patient.

Et si chaque passage en pharmacie devenait un point d’activation de la prévention ?
No comment yet.
Scooped by Gilbert C FAURE
March 26, 4:12 AM
Scoop.it!

#immunology #scienceswitzerland #science #education #research #innovation | Science-Switzerland

#immunology #scienceswitzerland #science #education #research #innovation | Science-Switzerland | Mucosal Immunity | Scoop.it
#Immunology | 𝗧 𝗖𝗲𝗹𝗹𝘀 𝗣𝗼𝘀𝗶𝘁𝗶𝗼𝗻 𝗧𝗵𝗲𝗺𝘀𝗲𝗹𝘃𝗲𝘀 𝗶𝗻 𝗟𝗼𝘄-𝗢𝘅𝘆𝗴𝗲𝗻 𝗭𝗼𝗻𝗲𝘀 𝘁𝗼 𝗖𝗼𝗺𝗺𝗮𝗻𝗱 𝗟𝘂𝗻𝗴 𝗗𝗲𝗳𝗲𝗻𝘀𝗲 | University of Basel researchers led by Jean de Lima found that specialized helper T cells migrate to oxygen-scarce edges of immune hubs during lung infection. There, they produce the so-called HIF-1α protein and release interleukin-21, directing macrophages, B cells, and natural killer cells into coordinated responses against respiratory pathogens. Using advanced imaging in influenza-infected mice and inducible knockout models, the team mapped how these cells position at hub boundaries to orchestrate defense networks.

The findings show tissue-resident immune hubs function as command centers for on-site protection rather than antibody factories. Professor Carolyn King's group validated the mechanism across secondary influenza infections and lung cancer models, showing broad therapeutic potential. This breakthrough enables design of inhalable vaccines that build immune defense directly in airways where viruses enter, potentially transforming respiratory disease prevention. The spatial coordination strategy also opens perspectives for tissue-targeted therapies that use the body's natural positioning systems to strengthen local immune responses at infection sites.

👇 Learn more & read the original publication: link in the comments 👇

🇨🇭 Follow #ScienceSwitzerland for the latest news and emerging trends on Swiss science, technology, education, and innovation >> swissinnovation.org
Follow us >> Science-Switzerland
#Science | #Education | #Research | #Innovation
No comment yet.
Scooped by Gilbert C FAURE
March 18, 6:49 AM
Scoop.it!

Pre-eclampsia linked to immune imbalance and vascular failure | Vejon Health Ltd posted on the topic

Pre-eclampsia linked to immune imbalance and vascular failure | Vejon Health Ltd posted on the topic | Mucosal Immunity | Scoop.it
Pre-eclampsia is often described as a disease of the placenta, but at its core it is also a disease of immune balance. When the maternal immune system becomes overactivated, the delicate vascular architecture of the placenta can begin to fail.

Recent data showing rising pre-eclampsia rates after the pandemic has prompted renewed interest in immune-vascular triggers. If spike protein interacts with macrophages and endothelial cells in the placenta, understanding that mechanism could become a crucial piece of the puzzle in protecting maternal and fetal health.

========================================================
Your Gut Readiness Assessment
https://lnkd.in/ezPm4wht
========================================================

You can also find us Here:

Substack: https://lnkd.in/ejXM5s68
Videos: https://lnkd.in/g3vJ8uXx
Courses: https://lnkd.in/ecmtMKhz
Rumble: https://lnkd.in/gG_HmbdN

#covid #medicine #research
Gilbert C FAURE's insight:

caution! from an anti-vax activist

No comment yet.
Scooped by Gilbert C FAURE
March 9, 5:19 AM
Scoop.it!

#biotechnology #vaccines #oralvaccines #pharmaceuticalindustry #infectiousdiseases #drugdevelopment #biotechinnovation #globalhealth #healthcareinnovation #clinicalresearch #lifesciences… | Justin Ma

#biotechnology #vaccines #oralvaccines #pharmaceuticalindustry #infectiousdiseases #drugdevelopment #biotechinnovation #globalhealth #healthcareinnovation #clinicalresearch #lifesciences… | Justin Ma | Mucosal Immunity | Scoop.it
Oral Vaccines Are Moving From Research to Reality

The global vaccine landscape may be entering a new phase — and oral vaccines are quickly becoming one of the most discussed innovations in infectious disease prevention.
In recent industry conversations across biotech and pharmaceutical research communities in the U.S., more attention is shifting toward oral vaccine platforms. Unlike traditional injections, oral vaccines could simplify distribution, improve patient compliance, and make large-scale immunization campaigns far more accessible — especially in regions where healthcare infrastructure is limited.
Several biotechnology companies are now accelerating research around oral delivery systems, mucosal immunity, and next-generation vaccine platforms. The idea is not only to prevent disease more effectively, but also to rethink how vaccines are manufactured, distributed, and administered globally.
For pharmaceutical companies and healthcare systems, this shift could represent more than just a scientific breakthrough. It may reshape public health logistics, vaccine accessibility, and global pandemic preparedness in the coming decade.
The question many people in the industry are asking now is:
If oral vaccines become widely scalable, could they fundamentally change the way the world approaches infectious disease prevention?
Curious to hear perspectives from people working across biotech, healthcare, and public health.

#Biotechnology #Vaccines #OralVaccines #PharmaceuticalIndustry #InfectiousDiseases
#DrugDevelopment #BiotechInnovation #GlobalHealth #HealthcareInnovation #ClinicalResearch
#LifeSciences #PublicHealth #BiotechInvesting #FutureOfMedicine #MedicalInnovation
No comment yet.
Scooped by Gilbert C FAURE
February 23, 4:27 AM
Scoop.it!

Boosting Mucosal Immunity in Next-Gen Vaccine Development | Stéphane Pillet posted on the topic | LinkedIn

Boosting Mucosal Immunity in Next-Gen Vaccine Development | Stéphane Pillet posted on the topic | LinkedIn | Mucosal Immunity | Scoop.it
A very insightful review from the Akiko Iwasaki's group on the potential to harness mucosal immunity in next-generation vaccine development.
While the rapid deployment of intramuscular mRNA vaccines was a landmark achievement in preventing severe COVID-19, intramuscular shots often fall short of providing sterilizing immunity.
Mucosal immunity represents a particularly promising avenue for improving vaccines against respiratory viruses, as it enables immune protection to be established directly at the site of viral entry and early replication.
Mucosal tissues, such as the respiratory tract, host locally regulated specialized immune cells that are functionally and spatially distinct. Reduction of infection and transmission requires engaging the mucosal immune response: a coordinated process beginning with epithelial pathogen sensing and culminating in the establishment of tissue-resident memory T (TRM) and B (BRM) cells, alongside robust local secretory IgA (SIgA) production. Unlike systemic IgG, nasal SIgA has demonstrated superior virus-neutralizing activity and greater breadth against antigenically drifted variants.
A promising strategy for advancing vaccine design is the heterologous prime-boost approach. Research suggests that intramuscular priming (to establish peripheral memory pools) followed by an intranasal boost can effectively "pull" memory cells to the respiratory mucosa.
However, the so-called 'mucosal' vaccines requires navigating complex physiological constraints, such as the mucociliary clearance system and the anionic mucus layer.
Moreover, the regulatory path for mucosal vaccines is primarily hindered by the lack of validated correlates of protection, making it difficult to predict efficacy and guide clinical trial designs. Additionally, the anatomical proximity of the nasal mucosa to the central nervous system necessitates rigorous safety evaluations to prevent neuro-olfactory spillover or unintended neuro-inflammation.
https://lnkd.in/eb5ZUMY4
No comment yet.
Scooped by Gilbert C FAURE
February 20, 3:00 AM
Scoop.it!

Nasal spray vaccine could ‘replace multiple jabs every year’

Nasal spray vaccine could ‘replace multiple jabs every year’ | Mucosal Immunity | Scoop.it
Nasal spray vaccine could ‘replace multiple jabs every year’Bookmark popoverRemoved from bookmarksClose popoverScientists at Stanford Medicine have developed a universal vaccine formula, tested on mice, that offers broad protection against various respiratory threats. The vaccine, delivered as a nasal spray, could protect against cold, flu, Covid, allergies, respiratory viruses, sepsis-causing bacteria, and even house dust mites. It works by mimicking the signals immune cells use to communicate during an infection, rather than targeting specific parts of a pathogen. If developed for humans, this vaccine could replace multiple annual jabs for winter respiratory infections and potentially protect against new pandemic bugs. While lead author Dr Bali Pulendran estimates human availability within five to seven years, other experts caution that a truly universal vaccine is still some way off due to safety considerations and the diversity of the human population.
No comment yet.
Scooped by Gilbert C FAURE
February 16, 6:27 AM
Scoop.it!

Une avancée importante en recherche vaccinale pour les 6 mois à 5 ans Une équipe dirigée par Guy Boivin, professeur au Département de pédiatrie et chercheur au Centre de recherche du CHU de Québec...

Une avancée importante en recherche vaccinale pour les 6 mois à 5 ans Une équipe dirigée par Guy Boivin, professeur au Département de pédiatrie et chercheur au Centre de recherche du CHU de Québec... | Mucosal Immunity | Scoop.it
Une avancée importante en recherche vaccinale pour les 6 mois à 5 ans

Une équipe dirigée par Guy Boivin, professeur au Département de pédiatrie et chercheur au Centre de recherche du CHU de Québec – Université Laval, a développé un vaccin expérimental administré par voie intranasale afin de protéger les jeunes enfants contre deux virus respiratoires majeurs : le métapneumovirus humain et le virus respiratoire syncytial (VRS). Ces deux agents infectieux sont responsables chaque année de nombreuses bronchiolites et pneumonies chez les jeunes enfants.

Les premières études menées sur des modèles animaux montrent des résultats très encourageants.
Cette avancée repose sur une plateforme vaccinale qui permet d’intégrer rapidement des éléments de différents virus pour créer de nouveaux candidats vaccins.
Découvrez tous les détails :
No comment yet.
Scooped by Gilbert C FAURE
February 10, 4:48 AM
Scoop.it!

Single-cell profiling reveals diverse γδ T cell subsets in ulcerative colitis

Scooped by Gilbert C FAURE
February 4, 6:39 AM
Scoop.it!

#mianpetsandvets #veterinarymedicine #felinehealth #vetmed #catvaccination #veterinaryeducation #catsoflinkedin | Mian Pets and Vets Clinic

#mianpetsandvets #veterinarymedicine #felinehealth #vetmed #catvaccination #veterinaryeducation #catsoflinkedin | Mian Pets and Vets Clinic | Mucosal Immunity | Scoop.it
Ever had a client ask: "Why does my kitten need to come TWO times for vaccines? Can't we just do it all at once?"

Let me break down the science in a way that might change how it act

🧬 The "Goldilocks Problem" of Maternal Immunity
Kittens are born with almost NO immunity from their mother during pregnancy. Unlike humans, cats have a special type of placenta that blocks antibody transfer before birth. Instead, 90-95% of protective antibodies come through colostrum in those critical first 16 hours of life (Claus et al., 2006).¹

But here's where it gets tricky...
These maternal antibodies are both a blessing and a curse:
✅ They protect vulnerable kittens from deadly diseases
❌ But they ALSO attack vaccine antigens, preventing the kitten from building their own immunity

This creates what scientists call the "window of susceptibility", a period where kittens are:
-Too vulnerable to fight off real infections
-Yet unable to respond to vaccines

Consider these exposure risks for "indoor-only" cats:
-Panleukopenia virus survives for YEARS in the environment and can be tracked indoors on shoes and clothing
-Multi-cat households where ONE cat goes outside creates risk for ALL cats

Here's what evidence-based feline vaccination looks like in #2026:
For Kittens: → Start at 6-8 weeks, continue every 2-4 weeks until 16-20 weeks → Core vaccines: FPV, FHV-1, FCV → FeLV for ALL kittens (remember that age-resistance curve!) → Rabies at 12-16 weeks → yearly booster
For Adult High-Risk Cats: → Annual booster of Core and Rabies

What challenges do you face while Vaccination?

#mianpetsandvets #VeterinaryMedicine #FelineHealth #VetMed #CatVaccination #VeterinaryEducation #CatsOfLinkedIn
No comment yet.
Scooped by Gilbert C FAURE
January 24, 7:33 AM
Scoop.it!

See Stéphane Paul’s activity on LinkedIn

See Stéphane Paul’s activity on LinkedIn | Mucosal Immunity | Scoop.it
Sign in or join now to see posts like this one and more.
No comment yet.
Scooped by Gilbert C FAURE
January 12, 9:07 AM
Scoop.it!

Une belle façon de démarrer 2026 ! Notre étude sur les taux de gamma-GT sanguins chez les nourrissons allaités vient d’être publiée dans le Journal of Pediatric Gastroenterology and Nutrition (JPGN...

Une belle façon de démarrer 2026 ! Notre étude sur les taux de gamma-GT sanguins chez les nourrissons allaités vient d’être publiée dans le Journal of Pediatric Gastroenterology and Nutrition (JPGN... | Mucosal Immunity | Scoop.it
Une belle façon de démarrer 2026 ! Notre étude sur les taux de gamma-GT sanguins chez les nourrissons allaités vient d’être publiée dans le Journal of Pediatric Gastroenterology and Nutrition (JPGN). Ce travail, issu de la thèse d’Audrey Ollivier-Garcia Cano, a été mené en collaboration avec Marion Marlinge, Paul Guerry et Aurélie MORAND .

En médecine vétérinaire, le taux de gamma-GT est utilisé comme marqueur du transfert d’immunoglobulines via le colostrum chez les bovins (les IgG ne passant pas la barrière placentaire). Certaines études suggéraient par ailleurs que le lait maternel est riche en gamma-GT. Nous avons donc mené une étude rétrospective chez des nourrissons ayant eu un bilan hépatique et consultant aux urgences pédiatriques, en excluant ceux présentant une infection ou un ictère.

Les gamma-GT sériques étaient significativement plus élevées chez les enfants allaités (101 UI/l) que chez les non-allaités (64 UI/l), avec un niveau intermédiaire (77 UI/l) pour l’allaitement mixte. Nous avons également confirmé la diminution des gamma-GT avec l’âge.

Ces résultats soulignent l’importance d’interpréter les dosages de gamma-GT en fonction du mode d’allaitement. Ils rappellent aussi la richesse des approches pluridisciplinaires.


https://lnkd.in/dEnBgETK
Scooped by Gilbert C FAURE
January 8, 1:43 PM
Scoop.it!

Gut virome dynamics: from commensal to critical player in health and disease | Nature Reviews Gastroenterology & Hepatology

Gut virome dynamics: from commensal to critical player in health and disease | Nature Reviews Gastroenterology & Hepatology | Mucosal Immunity | Scoop.it
The gut virome is a complex ecosystem characterized by the interplay of diverse viral entities, predominantly bacteriophages and eukaryotic viruses. The gut virome has a critical role in human health by shaping microbial community profiles, modulating host immunity and influencing metabolic processes. Different viral metagenomics approaches have revealed the remarkable diversity of the gut virome, showing individual-specific patterns that evolve over time and adapt dynamically to environmental factors. Perturbations in this community are increasingly associated with chronic immune and inflammatory conditions, metabolic disorders and neurological conditions, highlighting its potential as a diagnostic biomarker and therapeutic target. The early-life gut virome is particularly influential in establishing lifelong health trajectories through its interactions with diet, immune pathways and others, thereby contributing to inflammatory and metabolic regulation. This Review synthesizes current knowledge of gut virome composition, dynamics and functional relevance, critically evaluating evidence distinguishing causal from correlative roles in disease pathogenesis. The interactions of the virome with other microbiome components and host immunity are examined, and emerging translational applications, including phage therapy and biomarker development, are discussed. Integrating these insights while acknowledging methodological challenges provides a comprehensive framework for understanding the complex roles of the gut virome in health and disease. The gut virome is a complex ecosystem and has a critical role in human health. This Review outlines gut virome composition and functional relevance, and its role in human health and disease. Methodological challenges in advancing our knowledge of the gut virome are also discussed.
Scooped by Gilbert C FAURE
January 5, 4:21 AM
Scoop.it!

IgA-driven neutrophil activation underlies severe dengue disease after primary Zika virus infection in humans - Nature Immunology | Stéphane Paul

IgA-driven neutrophil activation underlies severe dengue disease after primary Zika virus infection in humans - Nature Immunology | Stéphane Paul | Mucosal Immunity | Scoop.it
IgA friends at mucossl level and foes at systemic level… a new proof…
No comment yet.